about
sameAs
Genomic survey of the non-cultivatable opportunistic human pathogen, Enterocytozoon bieneusiParasitic diarrheal disease: drug development and targetsStructure of a microsporidian methionine aminopeptidase type 2 complexed with fumagillin and TNP-470Treatment options for the eradication of intestinal protozoaTherapeutic strategies for human microsporidia infectionsThe fumagillin gene cluster, an example of hundreds of genes under veA control in Aspergillus fumigatusPolyenylpyrrole derivatives inhibit NLRP3 inflammasome activation and inflammatory mediator expression by reducing reactive oxygen species production and mitogen-activated protein kinase activationQuantitation of microsporidia in cultured cells by flow cytometry.Zoonotic potential of the microsporidia.Clinical significance of enteric protozoa in the immunosuppressed human population.System for expression of microsporidian methionine amino peptidase type 2 (MetAP2) in the yeast Saccharomyces cerevisiaeEnterocytozoon bieneusi Microsporidiosis in Stem Cell Transplant Recipients Treated with Fumagillin1Effective gene silencing in a microsporidian parasite associated with honeybee (Apis mellifera) colony declines.Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of theDiscovery of novel antigiardiasis drug candidates.Fumagillin: an anti-infective as a parent molecule for novel angiogenesis inhibitors.Antimicrosporidial activities of fumagillin, TNP-470, ovalicin, and ovalicin derivatives in vitro and in vivo.Microsporidiosis: current status.First cases of microsporidiosis in transplant recipients in Spain and review of the literatureAntimicrobial therapy for the treatment of opportunistic infections in HIV/AIDS patients: a critical appraisal.The state of research for AIDS-associated opportunistic infections and the importance of sustaining smaller research communities.Management of protozoa-related diarrhea in HIV infection.Enteric protozoa in the developed world: a public health perspective.Efficacy of gamma interferon and specific antibody for treatment of microsporidiosis caused by Encephalitozoon cuniculi in SCID mice.The fumagillin biosynthetic gene cluster in Aspergillus fumigatus encodes a cryptic terpene cyclase involved in the formation of β-trans-bergamoteneTreatment of parasitic diarrhea in HIV-infected patients.Generation of complexity in fungal terpene biosynthesis: discovery of a multifunctional cytochrome P450 in the fumagillin pathway.T cell response and persistence of the microsporidia.Disseminated microsporidiosis in a renal transplant recipient: case report and review of the literature.Biosynthesis of fungal meroterpenoids.Terpenoids from the Marine-Derived Fungus Aspergillus fumigatus YK-7.Inhibitory activity of human immunodeficiency virus aspartyl protease inhibitors against Encephalitozoon intestinalis evaluated by cell culture-quantitative PCR assaySuccessful Treatment of Disseminated Anncaliia algerae Microsporidial Infection With Combination Fumagillin and AlbendazoleIn vitro effects of resveratrol on the viability and infectivity of the microsporidian Encephalitozoon cuniculi.Detection and identification of Enterocytozoon bieneusi and Encephalitozoon species in stool and urine specimens by PCR and differential hybridization.Microsporidia: Obligate Intracellular Pathogens Within the Fungal Kingdom.Microsporidia infection in a mexican kidney transplant recipient.Therapeutic evaluation of polyamine analogue drug candidates against Enterocytozoon bieneusi in a SCID mouse model.Investigations into microsporidian methionine aminopeptidase type 2: a therapeutic target for microsporidiosis.Recombinant methionine aminopeptidase protein of Babesia microti: immunobiochemical characterization as a vaccine candidate against human babesiosis.
P2860
Q21559498-435B31B9-1977-47CA-AE20-581ECA28FF8DQ26776140-7D486DEF-D353-4616-BD7E-55B323D58AF2Q27656912-6345C6CD-987B-4558-8E87-F263459B50DBQ28255378-32DC4DFE-40C9-4153-95C7-F518EF0E525BQ28256376-06C8A0DA-0E8F-49B8-B6E7-39891E776499Q28534135-AEDB0B66-C70C-4C01-8F3C-746A145E399EQ28534137-ECB74433-6657-403F-B365-24EA67433565Q30342096-64FC4174-D202-4817-9B43-0E811B409DEEQ30351048-BDA9A3D5-33FB-4872-82C7-AC4FC656D493Q30381583-3E70B8C2-E5BC-4F5E-B3C3-06EA77E7CDD8Q33372298-4971C763-8A86-4389-B0F7-0BFD7515C8D0Q33441956-83C62635-5E05-4837-90E0-F8C04771060BQ34108949-257DCC6D-0542-4E40-978B-FD1C1EACA2ACQ34212799-9ACCD5AB-BC56-4618-9E87-BF9E3869F27AQ34597506-9B8CCED5-89B1-4769-908B-78DC8135D49BQ34659698-5A75E066-71F9-48E0-BF80-18F51A6DD8B5Q34680610-BB64C008-7492-4C9C-B361-9FBDCD807F0DQ35029765-03D97F46-1CF7-4A10-B8C0-CDCBA38874C6Q35066909-6AD1899D-8480-413A-8CF8-8AEF8AFE4EC6Q35557331-4AA69933-B762-47DE-95F7-EB075AC3D321Q35739010-7A389845-1E6A-4FA5-B986-34371CC42231Q35917249-21552144-00E8-4F30-928E-AD27898CAE8EQ36156094-D99A2423-9E7D-4712-B420-561B5A45E836Q36702992-81EC790E-7F74-4C30-868E-7A4DB5B2A4EAQ36840486-77F6F6D4-C388-493B-9EE3-490F826C3E4DQ37202848-5DD4F202-C87C-4938-8400-70929CC20F51Q37701669-76E34C80-05E8-4BB0-8083-F898F530C317Q37962612-4F22E59E-5844-44CF-93A4-FBB03291F3B4Q38129092-BCC24156-6FBE-4C23-8860-C22C00889C5EQ38615304-AE953D80-4692-4C38-9E55-E3B2AF7EEAD1Q38806698-945FD33B-A05B-434F-B5F6-85F51E48BA40Q40417013-754635B4-D8A2-4502-8981-3576A0328F27Q40516644-C354B8E5-6249-45E2-8EC9-5CDB786B0BC4Q40542097-F29FD92E-AE5D-4950-A7BA-226D10A98E52Q41040250-A9E1F18D-F12A-4181-94C3-CAE17A6BE3E5Q41653461-A3EAED52-50C6-4779-ACC6-366596B77827Q41915037-5DCD915E-4B79-4600-A806-23E8FAA14FE6Q42719579-365177A1-8BE5-4D94-A393-80A8ED3D9FC9Q42748289-6777027E-AA8B-49B3-BB6B-95C77BE8CD7EQ43173962-C589BBB1-35F8-496D-9D13-A2E297E77D3D
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Fumagillin treatment of intestinal microsporidiosis
@ast
Fumagillin treatment of intestinal microsporidiosis
@en
Fumagillin treatment of intestinal microsporidiosis
@nl
type
label
Fumagillin treatment of intestinal microsporidiosis
@ast
Fumagillin treatment of intestinal microsporidiosis
@en
Fumagillin treatment of intestinal microsporidiosis
@nl
prefLabel
Fumagillin treatment of intestinal microsporidiosis
@ast
Fumagillin treatment of intestinal microsporidiosis
@en
Fumagillin treatment of intestinal microsporidiosis
@nl
P2093
P3181
P356
P1476
Fumagillin treatment of intestinal microsporidiosis
@en
P2093
Amaury de Gouvello
Claudine Sarfati
Francis Derouin
Jean-Gérard Gobert
Jean-Michel Molina
Muriel Tourneur
Suna Balkan
P304
P3181
P356
10.1056/NEJMOA012924
P407
P577
2002-06-20T00:00:00Z